期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | NEUROSIGNALS (According to the latest JCR data, this journal is not indexed in the JCR.) LetPub Score 3.4
50 ratings
Rate
Reputation 3.7 Influence 2.4 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | NEUROSIGNALS | ||||||||||||||||||||||||
ISSN | 1424-862X | ||||||||||||||||||||||||
E-ISSN | 1424-8638 | ||||||||||||||||||||||||
h-index | 63 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | N.A.自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.karger.com/Journal/Home/224154 | ||||||||||||||||||||||||
在線稿件提交 | http://www.karger.com/Journal/Guidelines/224154#01 | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | S. Karger AG | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | SWITZERLAND | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 2002 | ||||||||||||||||||||||||
每年文章數 | 0每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 0.00% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( EUR1500; ) APC waiver:No Other charges: No Keywords: neurobiology、pharmacology、cell biology、neuroendocrinology、neurology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q0 N/A | ||||||||||||||||||||||||
索引 (SCI or SCIE) | |||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1424-862X%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[NEUROSIGNALS] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:03:01 評論於 Make a list of the most important keywords; Come up with a title that includes all the vocabulary; Delete unnecessary/repetitive words and link the remaining ones; Rewrite the title after removing non-essential information(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:03:22 評論於 Translation into English(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 09:34:54 評論於 How to write a better article title?(0) 讚! | 陶宜三岁啦 |
作者: Oswald Edie 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 16:12:20 評論於 Is there a technique to writing article titles?(0) 讚! | Oswald Edie |
作者: 百花腊月 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-25 17:12:51 評論於 Please translate the following paragraph into English and Japanese, and use ":" and ":" as headings(0) 讚! | 百花腊月 |
作者: 安志小娘子 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-06-27 12:50:48 評論於 Was it included this year? Acceptance rate: about 5% Review time: about 6 months are all about contribution. Contribution also means reviewing for a long time. Few masterpieces are included every year(0) 讚! | 安志小娘子 |
作者: 百花腊月 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-01-10 16:15:18 評論於 Review speed: 6.0 | Submission acceptance rate: 5.0 Experience sharing: All are commissioned works, and reviewing takes a very long time, with only a few major works being included each year(0) 讚! | 百花腊月 |
作者: 凌霄高洁 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-01 13:01:54 評論於 This journal is now rated 2.5, a significant increase from last year. Is there a possibility of reaching 3 points?(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-05-24 10:31:28 評論於 Seventeen articles published in one year, no one dares to submit! Even if you win, it will take 10 years(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 16:43:06 評論於 Will it drop to 3 points next year? It won't be worth it if it drops below 3 points(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us